Author

J. Neugebauer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Damerau· 1 shared A. Hombrouck· 1 shared A. Trumpp· 1 shared B. Pillay· 1 shared C. Conrad· 1 shared D. Cassiman· 1 shared D. Daelemans· 1 shared E. Frances Rabanal· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Damerau

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 25, 2023

Human ADA2 deficiency is characterized by the absence of an intracellular hypoglycosylated form of adenosine deaminase 2

L. Ehlers, M. Wouters, A. Hombrouck…·I. Meyts

The paper identifies an intracellular hypoglycosylated form of ADA2 absent in DADA2 patients, linking its absence to reduced deaminase activity and variant pathogenicity.

DOI 10.1101/2023.10.25.564037

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivApr 6, 2017

Resolving Drug Effects In Patient-Derived Cancer Cells Links Organoid Responses To Genome Alterations

J. Neugebauer, F. M. Zickgraf, J. Park…·C. Conrad

The paper compares drug responses in ovarian cancer organoids and monolayer cultures, finding differences in drug efficacy and genomic associations.

DOI 10.15252/msb.20177697

humanproteomics

𝕏 PostBluesky